Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Schering settles with SEC

This article was originally published in The Rose Sheet

Executive Summary

Schering-Plough will pay $1 mil. civil penalty to the Securities and Exchange Commission to settle allegations the firm violated Regulation Fair Disclosure, SEC announces Sept. 9. If approved, penalty will be the largest SEC has obtained from a company in violation of the law. In a separate settlement, former Schering-Plough chairman and CEO Richard Kogan agrees to pay a $50,000 civil fine to the agency, marking the first time an individual has been penalized under the reg. SEC alleged that Kogan disclosed market-sensitive information, including the firm's earnings prospects, to select investors late last year. The exec stepped down from his post in November and was replaced by Fred Hassan in April (1"The Rose Sheet" April 28, 2003, In Brief)...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS011520

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel